Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Intestinal ischemia/reperfusion injury: defining the role of the gut microbiome.

Kinross J, Warren O, Basson S, Holmes E, Silk D, Darzi A, Nicholson JK.

Biomark Med. 2009 Apr;3(2):175-92. doi: 10.2217/bmm.09.11.

PMID:
20477509
2.

Microbial influences on the small intestinal response to radiation injury.

Packey CD, Ciorba MA.

Curr Opin Gastroenterol. 2010 Mar;26(2):88-94. doi: 10.1097/MOG.0b013e3283361927. Review.

3.

Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice.

Kovacic JC, Gupta R, Lee AC, Ma M, Fang F, Tolbert CN, Walts AD, Beltran LE, San H, Chen G, St Hilaire C, Boehm M.

J Clin Invest. 2010 Jan;120(1):303-14. doi: 10.1172/JCI40364. Epub 2009 Dec 28.

4.

Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection.

Ma J, Wang J, Wan J, Charboneau R, Chang Y, Barke RA, Roy S.

Infect Immun. 2010 Feb;78(2):830-7. doi: 10.1128/IAI.00914-09. Epub 2009 Dec 7.

5.

Wound healing responses at the gastrointestinal epithelium: a close look at novel regulatory factors and investigative approaches.

Karrasch T, Jobin C.

Z Gastroenterol. 2009 Dec;47(12):1221-9. doi: 10.1055/s-0028-1109766. Epub 2009 Dec 3. Review.

PMID:
19960401
6.

STATs in cancer inflammation and immunity: a leading role for STAT3.

Yu H, Pardoll D, Jove R.

Nat Rev Cancer. 2009 Nov;9(11):798-809. doi: 10.1038/nrc2734. Review.

7.

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing.

Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr HA, Hirth S, Weigmann B, Wirtz S, Ouyang W, Neurath MF, Becker C.

J Exp Med. 2009 Jul 6;206(7):1465-72. doi: 10.1084/jem.20082683. Epub 2009 Jun 29.

8.

Mechanisms of opioid-mediated inhibition of human T cell receptor signaling.

Börner C, Warnick B, Smida M, Hartig R, Lindquist JA, Schraven B, Höllt V, Kraus J.

J Immunol. 2009 Jul 15;183(2):882-9. doi: 10.4049/jimmunol.0802763. Epub 2009 Jun 26.

9.

Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility.

Uronis JM, Mühlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C.

PLoS One. 2009 Jun 24;4(6):e6026. doi: 10.1371/journal.pone.0006026.

10.

New insights into the role of endogenous opioids in the pathogenesis of gastrointestinal and liver disease.

Mani AR, Moore KP.

Gut. 2009 Jul;58(7):893-5. doi: 10.1136/gut.2007.141648. Review. No abstract available.

PMID:
19520882
11.

Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.

Granata R, Trovato L, Gallo MP, Destefanis S, Settanni F, Scarlatti F, Brero A, Ramella R, Volante M, Isgaard J, Levi R, Papotti M, Alloatti G, Ghigo E.

Cardiovasc Res. 2009 Jul 15;83(2):303-12. doi: 10.1093/cvr/cvp090. Epub 2009 Mar 17.

12.

Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice.

Joo YE, Karrasch T, Mühlbauer M, Allard B, Narula A, Herfarth HH, Jobin C.

PLoS One. 2009;4(2):e4562. doi: 10.1371/journal.pone.0004562. Epub 2009 Feb 23.

13.

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L, Karin M.

Cancer Cell. 2009 Feb 3;15(2):103-13. doi: 10.1016/j.ccr.2009.01.001. Erratum in: Cancer Cell. 2009 Mar 3;15(3):241.

14.

Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.

Li R, Wong GT, Wong TM, Zhang Y, Xia Z, Irwin MG.

Anesth Analg. 2009 Jan;108(1):23-9. doi: 10.1213/ane.0b013e3181884ba6.

PMID:
19095826
15.

A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis.

Snider AJ, Kawamori T, Bradshaw SG, Orr KA, Gilkeson GS, Hannun YA, Obeid LM.

FASEB J. 2009 Jan;23(1):143-52. doi: 10.1096/fj.08-118109. Epub 2008 Sep 24.

16.

The opioid antagonist naltrexone improves murine inflammatory bowel disease.

Matters GL, Harms JF, McGovern C, Fitzpatrick L, Parikh A, Nilo N, Smith JP.

J Immunotoxicol. 2008 Apr;5(2):179-87. doi: 10.1080/15476910802131469.

PMID:
18569389
17.

Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation.

Steinbrecher KA, Harmel-Laws E, Sitcheran R, Baldwin AS.

J Immunol. 2008 Feb 15;180(4):2588-99.

18.

Microbial influences in inflammatory bowel diseases.

Sartor RB.

Gastroenterology. 2008 Feb;134(2):577-94. doi: 10.1053/j.gastro.2007.11.059. Review.

PMID:
18242222
19.

Epithelial restitution and wound healing in inflammatory bowel disease.

Sturm A, Dignass AU.

World J Gastroenterol. 2008 Jan 21;14(3):348-53. Review.

Supplemental Content

Support Center